The eternal dilemma in Clinical Development hiring: specialist physician or industry-experienced generalist?
Camilla Fedi
Medical Affairs and Clinical Development Recruiter |90% CV to interview ratio| Biotech, Pharma, and CROs | USA & Canada
In the complex world of clinical development, companies face a persistent hiring dilemma: should they bring in a specialty physician straight from academia or an industry-experienced generalist? As therapies evolve and disease states become more nuanced, the need for both specialist and generalist physicians in clinical development is?evident. However, deciding which type of physician to hire can significantly?impact?a company’s long-term success.?
Increasingly, companies are opting for board-eligible physicians to fill specialized roles. For instance, hiring an endocrinologist for a metabolic drug development program offers a competitive advantage with deep, specialized knowledge. However, while this approach provides unparalleled?expertise?in niche therapeutic areas, it?may?also raise some key concerns. These concerns include the adaptability of the physician to a fast-paced industry environment, their willingness to thrive in a collaborative setting after coming from an independent academic or private practice, and whether the company can afford to compete with the high salaries offered in private practice. Additionally, companies need to evaluate whether their pipeline can support the long-term retention of a specialist, especially?in the event of?a failed project.?
Specialist vs. Generalist: success stories and industry experiences
When deciding between a specialist and a generalist,?it’s?important to weigh both their potential impact and the risks they pose.??
In the past, generalists were more in demand across the industry. However, in my recent experience, more placements in clinical development are trending towards specialist physicians. CROs, like pharma and biotech companies, have also embraced this trend. These candidates often appeal to?CROs?because they mirror the highly specialized models that sponsors tend to follow, and they bring the niche?expertise?required?due to the increasing complexity of clinical studies. Despite this shift,?it’s?crucial to remember that generalist physicians?remain?a viable?alternative. Generalists with extensive industry experience offer a different set of advantages. They bring broad therapeutic knowledge, adaptability, and a continuous learning mindset — qualities that make them well-suited to roles that require flexibility across multiple projects or therapeutic areas.
One of the key points I want to emphasize is that although specialists might seem like the more refined option, generalists can contribute immense value, particularly in drug development environments that demand versatility and a broad perspective.
Risks of hiring specialty physicians in Clinical Development
Hiring specialty physicians for niche roles, particularly in clinical development, comes with its share of challenges. Firstly, there is the issue of higher salaries. Specialists often command top-tier compensation, which may not be?feasible?for every organization. Moreover, specialists tend to have deep knowledge in only one therapeutic area. If a company needs to pivot or has multiple projects in areas outside the specialist’s?expertise, they may not be as effective as a generalist.?
Specialists also face challenges in adapting to the clinical trial process. Generalists, by virtue of working across different therapeutic areas, quickly?acquire?knowledge in various fields and often become adept at managing the complexities of clinical trials. Specialists, on the other hand, might not have the same level of trial management?expertise. Additionally, specialists may be less coachable or manageable, especially if they have?spent years?operating?with a level of autonomy in private practice or academia.?There’s?a risk that they might feel more self-entitled, which can make integration into a team-oriented environment more difficult.?
The future of Clinical Development Specialists on then rise
Looking ahead, the demand for specialists is likely to increase over the next five to ten years. The complexity of new therapies, such as gene and cell therapy, and the increasing prevalence of rare diseases will drive this shift. Companies developing treatments for these conditions often prioritize hiring physicians who are experts in a particular disease state, even if they are less experienced in clinical trials. This focus on disease-specific?expertise?is becoming more prominent, particularly in fields like oncology, neurology, and rare diseases, where in-depth knowledge is critical to advancing therapies.?
Generalists will?likely continue?to play?an important role?in early-phase clinical development, where the process can be more manageable, and the need for specialized?expertise?is not as pronounced. Specialists, meanwhile, are expected to dominate in late-phase trials, where the stakes are higher, and the need for disease-specific knowledge becomes crucial.?
领英推荐
Financial and operational considerations: Specialists vs. Generalists
When deciding between a specialist and a generalist, financial and operational considerations are key. Specialists typically come with a higher price tag, not only in terms of salary but also in terms of long-term retention. If a clinical asset fails, a company may struggle to?retain?a specialist whose?expertise?is no longer needed.?
In contrast, generalists can often be repurposed for other projects, providing greater flexibility and cost-effectiveness.?Generalists are also more versatile when it comes to managing multiple assets across different therapeutic areas. This adaptability can be particularly valuable for smaller companies or those with pipelines that span several therapeutic fields. Specialists, on the other hand, are more likely to focus solely on one asset, making them less flexible in terms of workload and potentially increasing the risk of turnover if that asset fails.?
Practical advice for hiring teams
For?hiring?teams tasked with deciding whether to hire a generalist or a specialist, a few key considerations can help guide the decision:?
Management skills: generalists vs. specialists
Finally, there is a distinct difference in how generalists and specialists approach management. Generalists, accustomed to working across various therapeutic areas, often develop a more collaborative management style, working effectively with cross-functional teams. Specialists, however, may be more accustomed to working independently and may need more guidance and coaching to adapt to the collaborative nature of clinical development teams.?
In conclusion, while there is no universal solution to the specialist vs. generalist debate, the decision?ultimately depends?on a company’s unique needs,?the complexity of the research, and pipeline.?Both generalists and specialists bring unique strengths, and?leveraging?a mix of these talents can?greatly?benefit?the clinical development landscape.?
Hiring managers must carefully consider whether the complexity of the research calls for a generalist or a specialist.?If the decision leans towards hiring specialists, managing expectations around timelines and compensation becomes essential.?Furthermore, partnering with specialized recruiters can streamline the process of sourcing top-tier specialist talent, ensuring the right fit, at the right time, for the organization’s needs.?
If you'd like to have a more in-depth conversation about this please reach out here on Linkedin or by sending me an email to [email protected]
International Healthcare Consultant | Professor I Cardio-thoracic Surgeon I Critical Care I Immunologist I Emotional Health Champion I Domestic/International Medical Concierge & Health Advisor| Healthcare Board Member
1 个月Thank you Camilla Fedi for this timely article. Many specialists are dissatisfied with their clinical role and wish to transition to corporate however the journey is not always easy for many of the reasons you articulate. The CRO's, when they hire specialists, it should be project specific hires and for a limited time. As such when the project is completed that specialist leaves and re-enters the unemployed "pool" but now with some industry experience making him/her that much more attractive to the next CRO looking to fill a clinical development role. The clinical development sector is not just challenged with the dilemma of specialist vs. generalist but with limited pipelines. Perhaps more focus should be on drug repurposing (https://www.drugdiscoveryonline.com/doc/finding-new-treatments-in-old-therapies-0001) than the phenotype of the employee.
Medical Director | Scientific Director | Medical Affairs | Global Clinical Trials | Strategy | Clinical Imaging | Rheumatology | Gastroenterology | Neuromuscular | Rare diseases | Neurology | CNS | Oncology | Obesity
1 个月This article comes at a time when I was wondering about this same phenomenon, as I find myself impacted due to this shift.
??Deloitte Ireland BPS: LSHC Industry Lead | ??Tinkerer | ??Founder | ??Storyteller | ?? Market Voyager | ??Futurist | ??AI Explorer | ??Building Meaningful Connections | Passionate about ??Business & ??Entrepreneurship
1 个月Great share thanks!